Vaccinex, Inc. (VCNX) financial statements (2021 and earlier)

Company profile

Business Address 1895 MOUNT HOPE AVE
ROCHESTER, NY 14620
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2019
12/31/2018
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments320
Cash and cash equivalents36
Short-term investments 14
Receivables11
Other undisclosed current assets01
Total current assets:421
Noncurrent Assets
Property, plant and equipment11
Total noncurrent assets:11
TOTAL ASSETS:522
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities77
Accounts payable32
Accrued liabilities44
Total current liabilities:77
Noncurrent Liabilities
Total liabilities:77
Stockholders' equity
Stockholders' equity attributable to parent(26)(9)
Common stock00
Treasury stock, value(0)(0)
Additional paid in capital222208
Accumulated deficit(249)(217)
Stockholders' equity attributable to noncontrolling interest2424
Total stockholders' equity:(2)15
TOTAL LIABILITIES AND EQUITY:522

Income statement (P&L) ($ in millions)

12/31/2019
12/31/2018
Revenues11
Cost of revenue(0)(1)
Gross profit:0(0)
Operating expenses(32)(27)
Operating loss:(32)(27)
Nonoperating income
(Other Nonoperating income)
00
Interest and debt expense (3)
Loss from continuing operations before equity method investments, income taxes:(32)(30)
Other undisclosed income from continuing operations before income taxes 0
Net loss available to common stockholders, diluted:(32)(30)

Comprehensive Income ($ in millions)

12/31/2019
12/31/2018
Net loss:(32)(30)
Comprehensive loss, net of tax, attributable to parent:(32)(30)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: